MR. GREG PERRY
Greg Perry joined IFPMA on 1st February 2018 and has responsibility for IFPMA’s external outreach and stakeholder engagement in global health topics including innovation, access, and the international regulatory environment. Greg Perry brought with him more than 20 years’ leadership and advocacy experience in the public healthcare arena.
Prior to joining IFPMA, Greg worked as Executive Director of the Medicines Patent Pool, which he joined in 2013 and as Director General of the European Generic Medicines Association (1999 – 2013) in Brussels. Previously he worked as a partner in a UK public affairs company as a European Union policy advisor to corporate and non-governmental organizations, and before that as a Parliamentary Advisor to Members of the European Parliament. Greg is a Member of the Advisory Council of the Organization for Professionals in Regulatory Affairs (TOPRA) and is a former member of the Standing Advisory Committee before the European Patent Office (SACEPO). Greg also holds the Golden Cross of Merit of the Republic of Poland.
DR. MICHEL HAMALA SIDIBE
Mr. Sidibé is a renowned tireless champion of African-owned solutions and has been an outspoken advocate for local pharmaceutical production of medicines and other essential health commodities. He contributed to the efforts towards access to quality and safe medicines and vaccines and in fighting global inequities.
In April 2021, he was appointed African Union Special Envoy for AMA. Thanks to his high-level advocacy efforts, the treaty entered into force on 5 November, much more quickly than expected.
A former Minister of Health and Social Affairs for Mali (2019-2020), Sidibé has championed a people centered approach to health and development for over 40 years.
He served as Executive Director of UNAIDS, holding the rank of Under-Secretary-General of the United Nations (2009-2019). Prior to joining UNAIDS, Mr. Sidibé worked at UNICEF and for Terre des Hommes, where his passion for advancing global health and social justice began.
Under his leadership at UNAIDS, more than 25 million people started life saving HIV treatment.
In 2021 he was appointed a board member of The Global Commission on Drug Policy.
An economist by training, Michel Hamala Mr. Sidibé is the recipient of various African and global awards, including honorary doctorates from world’s leading universities.
MS. SELMA KITTA
Project Director with more than 17 years’ experience in line, project and operation management. I was involved in more than 150 trials from Phase I to Phase IV for different therapeutic indications, including but not limited to Infectious diseases like SARS COV, rare diseases with an extensive experience in the SCD indication, neurology, …etc.
For the past 2 years, I was involved mainly in setting up SARS-COV2 trials in Africa then in Europe and USA. I’m highly passionate about running clinical trials and strive to build capacity in Africa.
MS. LENIAS HWENDA
Lenias Hwenda is the Founder and CEO of Medicines for Africa, a social enterprise that improves access to treatment. She is a recognized influential thought leader and practitioner who continues to contribute at the highest stage of international health affairs working with African governments in the World Health Organization for more than a decade. She has participated in and led a number of intergovernmental and industry negotiations seeking the best solutions to meet the health needs of vulnerable people around the world. Lenias recently co-chaired the historic World Health Organization negotiations between governments on improving the transparency of markets for medicines, vaccines, and other health products during the World Health Assembly in 2019. She is a tireless advocate using her deep knowledge of public health, international affairs and health security to drive initiatives that improve access to healthcare by underserved communities. She hosts “Let´s Talk about health in Africa” Podcast conversations highlighting challenges and opportunities for improving the health of Africans.
We Accept:
Ads
